Shares of Dechra Pharmaceuticals plc (LON:DPH) reached a new 52-week high during trading on Friday . The company traded as high as GBX 2,149 ($28.51) and last traded at GBX 2,149 ($28.51), with a volume of 67,668 shares traded. The stock had previously closed at GBX 2,122 ($28.15).

A number of research firms have recently commented on DPH. Jefferies Group LLC boosted their price objective on Dechra Pharmaceuticals plc from GBX 1,565 ($20.76) to GBX 1,868 ($24.78) and gave the stock a “hold” rating in a research note on Tuesday, September 5th. N+1 Singer reissued a “buy” rating and issued a GBX 1,666 ($22.10) price objective on shares of Dechra Pharmaceuticals plc in a research note on Thursday, July 6th. Numis Securities Ltd reissued an “add” rating and issued a GBX 1,890 ($25.07) price objective on shares of Dechra Pharmaceuticals plc in a research note on Thursday, July 6th. Investec reissued a “buy” rating and issued a GBX 1,840 ($24.41) price objective on shares of Dechra Pharmaceuticals plc in a research note on Thursday, July 6th. Finally, Stifel Nicolaus reissued a “hold” rating and issued a GBX 1,550 ($20.56) price objective on shares of Dechra Pharmaceuticals plc in a research note on Tuesday, July 11th. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Dechra Pharmaceuticals plc has an average rating of “Buy” and a consensus price target of GBX 1,784 ($23.66).

The stock has a 50-day moving average price of GBX 1,993.54 and a 200 day moving average price of GBX 1,815.50. The company’s market cap is GBX 2.00 billion.

The business also recently declared a dividend, which will be paid on Friday, November 17th. Stockholders of record on Thursday, October 26th will be paid a GBX 15.33 ($0.20) dividend. The ex-dividend date is Thursday, October 26th. This represents a dividend yield of 0.74%. This is an increase from Dechra Pharmaceuticals plc’s previous dividend of $6.11.

In other news, insider Ian Page sold 54,910 shares of the stock in a transaction on Tuesday, September 19th. The stock was sold at an average price of GBX 2,024 ($26.85), for a total value of £1,111,378.40 ($1,474,172.17).

COPYRIGHT VIOLATION WARNING: “Dechra Pharmaceuticals plc (DPH) Sets New 52-Week High at $2,149.00” was posted by Watch List News and is the property of of Watch List News. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be read at https://www.watchlistnews.com/dechra-pharmaceuticals-plc-dph-sets-new-52-week-high-at-2149-00/1613377.html.

About Dechra Pharmaceuticals plc

Dechra Pharmaceuticals PLC is engaged in veterinary pharmaceuticals and related products business. The Company is engaged in development, manufacture and marketing of products for veterinarians. Its segments include European Pharmaceuticals, North American (NA) Pharmaceuticals and Pharmaceuticals Research and Development.

Receive News & Ratings for Dechra Pharmaceuticals plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dechra Pharmaceuticals plc and related companies with Analyst Ratings Network's FREE daily email newsletter.